Navigation Links
Cleveland Clinic Selects Laparoendoscopic Single-Site Surgery (LESS) as One of the Top Ten Innovations of 2009
Date:1/29/2009

Founder of Leader In LESS Instrumentation Is Selected for Industry Leader LESS Panel at Cleveland Clinic Medical Innovation Summit

FRAMINGHAM, Mass., Jan. 29 /PRNewswire/ -- Cambridge Endo, a pioneer in the rapidly emerging LESS (also called Single Port Access Laparoscopic Surgery or SPA) market, is pleased to announce that its president and founder, Woojin Lee, was among the industry leaders selected to be on a LESS panel at the Cleveland Clinic Medical Innovation Summit. Cambridge Endo developed, manufactures and markets the innovative Autonomy(TM) Laparo-Angle(TM) articulating instruments which, it believes, is the enabling technology that will drive the rapid uptake of this major advance in laparoscopic surgery.

In traditional laparoscopic surgery, the surgeon makes three to six "keyhole" incisions in multiple sites, inserts instrumentation into each "keyhole" and performs the surgery. In LESS/SPA, only one incision is made through the umbilicus (navel). All of the instruments go through this single "keyhole." Said Lee, "LESS/SPA has been called 'scarless' surgery."

According to the Cleveland Clinic, the key criteria used in selecting LESS/SPA as one of the top 10, "game changing" innovations of 2009 were:

  • "Have significant potential for short-term clinical impact (either a major improvement in patient benefit or an improved function that enhances healthcare delivery)
  • Have a high probability of success
  • Be on the market or close to being introduced
  • Have sufficient data available to support its nomination."

Inderbir S. Gill, M.D., Chairman of Urology at the Cleveland Clinic commented, "[we] performed LESS live-donor nephrectomies in nine consecutive kidney donors for kidney transplantation. All aspects of kidney harvesting were completed though the navel. Instead of a visible six-inch scar and a six-week recovery period, patients recovered within two weeks and had a tiny scar hidden by their belly button. Because it only uses one port with multiple channels for the surgeon to simultaneously pass various surgical instruments, LESS may also reduce complications that might occur after traditional open and even laparoscopic abdominal surgery. My patients report less discomfort and have faster recoveries compared to those undergoing traditional laparoscopy." According to the clinic, the return to work time for single port surgery donors is about 17 days vs. 51 for traditional multi-incision laparoscopic procedures.

Commented Lee, "Donor nephrectomy is but one of the many laparoscopic surgical procedures that, we believe, will be converting to LESS/SPA in the coming years. Already, LESS/SPA procedures have been performed with Autonomy articulating instruments in many general, urologic, and gynecologic surgical procedures. Together, over two million of these procedures are currently performed laparoscopically in the U.S. each year. This is a very large addressable market."

About Cambridge Endo

Cambridge Endo is a privately held medical device company that designs, develops and manufactures innovative articulating laparoscopic instruments. The Autonomy(TM) Lapro-Angle(TM) product line is designed to be an enabling technology for LESS/SPA. Autonomy articulating instruments are also used in many traditional laparoscopic procedures by general, bariatric, urologic, and gynecologic surgeons.

Cambridge Endo is headquartered in Framingham, MA. For more information about Cambridge, please visit www.cambridgeendo.com.

    Contact:
    Woojin Lee, Ph.D.
    508-405-0790 ext. 104
    wlee@CambridgeEndo.com


'/>"/>
SOURCE Cambridge Endo
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Sangamo BioSciences Appoints Paul Cleveland to Its Board of Directors and Chair of Audit Committee
2. Cleveland Clinic Recognizes New Strategies for Creating Vaccines for Avian Flu as a Top Ten Medical Innovation for 2009
3. Cleveland Clinic Recognizes Circulating Tumor Cell Technology as Top Medical Innovation for 2009
4. NanoMedicine Summit Returns to Cleveland, September 25-26
5. University Hospitals Case Medical Center, Cleveland, USA and Cardialysis BV, Rotterdam, the Netherlands Enter Strategic Alliance to Found Cardialysis Cleveland
6. Cleveland Clinic and Rutgers to Lead Newly Formed Institute for War Wounded
7. Siemens Signs Multi-Year Agreement With Cleveland Clinic to Deploy Enterprise-Wide Cardiology PACS
8. Cleveland+ Region Attracts $318 Million in New Venture Investment in 2007
9. Cleveland Clinic-Led Research Uncovers New Mechanism That Heightens Risk of Heart Disease
10. Perceptive Informatics Reaches Key Milestone Marking 10 Million IVRS Interactions In Support of Clinical Trials
11. ClearTrial Selected to Lead Industry Panel on Managing Clinical Trial Cash Flow and Accruals at CBI Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:5/26/2016)... (PRWEB) , ... May 26, 2016 , ... ... FireflySci cuvettes are used in leading laboratories all over the globe. Their ... , In addition to manufacturing awesome cuvettes, FireflySci makes spectrophotometer calibration standards that ...
(Date:5/25/2016)... (PRWEB) , ... May 25, 2016 , ... ... for information (RFI) issued by the Office of the National Coordinator for Health ... experience, and determines if clinically relevant data were available when and where it ...
(Date:5/24/2016)... ... May 24, 2016 , ... Cell therapies for ... be accelerated by research at Worcester Polytechnic Institute (WPI) that yielded a newly ... tissue regeneration. , The novel method, developed by WPI faculty members Raymond Page, ...
(Date:5/23/2016)... ... May 23, 2016 , ... PrecisionAg® Media ... in 2017 and Beyond. The paper outlines the key trends that are creating ... , “We’ve witnessed a lot of highs and lows as the precision agriculture ...
Breaking Biology Technology:
(Date:4/28/2016)... GOTHENBURG, Sweden , April 28, 2016 ... 1,491.2 M (139.9), up 966% compared with the first quarter of ... Operating profit totaled SEK 589.1 M (loss: 18.8) and the operating ... SEK 7.12 (loss: 0.32) Cash flow from operations was ... , The 2016 revenue guidance is unchanged, SEK 7,000-8,500 M. ...
(Date:4/15/2016)... , April 15, 2016 ... "Global Gait Biometrics Market 2016-2020,"  report to their ... ) , ,The global gait biometrics market ... 13.98% during the period 2016-2020. Gait ... which can be used to compute factors that ...
(Date:3/29/2016)... BOCA RATON, Florida , March 29, 2016 /PRNewswire/ ... ("LegacyXChange" or the "Company") LegacyXChange "LEGX" and SelectaDNA/CSI Protect ... Synthetic DNA in ink used in a variety of ... preventing theft. Buyers of originally created collectibles from athletes ... authenticity through forensic analysis of the DNA. ...
Breaking Biology News(10 mins):